At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Enhancing Adaptations to Exercise
In Brief
A Phase 3 clinical trial evaluating n3-PUFA, Placebo, and 2 other interventions for Inflammation. Completed, enrolled 63 participants across 1 site.
Detailed Summary
Researchers are trying to understand how chronic inflammation affects muscle function and responses to exercise.They are also trying to determine if suppressing chronic inflammation using omega-3 fatty acids (n3-PUFA) restores skeletal muscle function and exercise responsiveness in older adults.
Study Details
Timeline
Interventions
The DHA/EPA softgels will each contain \~465mg of EPA and \~375mg of DHA for a total daily dosage of 3.4g/day. Additionally, each capsule will contain SCI's proprietary Advance Lipid TechnologiesTM (ALTTM) containing the surfactants polysorbate 80, NF (\~381 mg) and poloxamer 237, NF (\~8.8 mg).
Looks exactly like the study drug but contains soybean oil with no active ingredient.
Two muscle biopsies from the upper part of one leg. A small (\~1cm) incision will be made through the skin, and a needle will then be used to remove the muscle.
Measure of body fat percentage, skeletal muscle mass, body water, and visceral fat.